Turning Baby Teeth Into Cell Therapy

SHED cells show early promise as a potential regenerative therapy in cerebral palsy research

March 26, 2026
3 min

The Medicine Maker

Overview

This study evaluates the safety and potential functional effects of stem cell therapy derived from human exfoliated deciduous teeth (SHED) in children with cerebral palsy. Initial findings suggest that the treatment is well tolerated and may lead to improvements in motor and functional assessments, although further research is needed to confirm efficacy.

Background

Cerebral palsy affects approximately 2-3 children per 1,000 live births and is characterized by early brain injury leading to movement and posture issues. Current treatments primarily focus on rehabilitation and symptom management, lacking interventions that address the underlying neurological damage. The exploration of SHED cells as a regenerative therapy presents a novel approach to potentially improve outcomes in this patient population.

Data Highlights

No serious adverse events were reported, and some participants showed improvements in motor assessments following SHED therapy.

Key Findings

SHED cells are derived from naturally shed baby teeth and can be collected noninvasively.
The treatment was generally well tolerated with no serious adverse events reported.
Some participants exhibited improvements in motor and functional assessments post-treatment.
SHED cells possess neurotrophic and immunomodulatory properties that may aid in neuronal repair.
Further research is necessary to establish long-term safety and efficacy of SHED therapies.

Clinical Implications

Highlight the necessity for larger controlled trials and suggest specific research directions.

Conclusion

The initial findings on SHED therapy for cerebral palsy are promising, indicating a need for further investigation to confirm its clinical effectiveness and safety in larger populations.